Depiction of Prostate Cancer Treatment Alternatives in Greece
Completed
- Conditions
- Locally Advanced or Metastatic Prostate Cancer.
- Registration Number
- NCT00733213
- Lead Sponsor
- AstraZeneca
- Brief Summary
A retrospective, registry analysis of the socio-economic and demographic characteristics of patients suffering from locally advanced or metastatic prostate cancer, as well as the depiction of the therapeutic algorithms followed in the Greek clinical practice.
* Target Group: Patients with locally advanced or metastatic prostate cancer.
* The first 10 consecutive patients records that meet the entry criteria.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 310
Inclusion Criteria
- Patients diagnosed with Locally advanced or Metastatic Prostate Cancer after 2002.
- Patients that received Hormonal therapy.
Read More
Exclusion Criteria
- Males that are aged less than 18 years
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of patients treated by each treatment alternative. Between 2002 - 2008
- Secondary Outcome Measures
Name Time Method To depict sociodemographic characteristics and comorbidities. Between 2002 - 2008
Trial Locations
- Locations (1)
Research Site
🇬🇷Xsanthi, Greece